First generic remdesivir will be sold by Bangladesh drug maker
Beximco was not issued a license by Gilead to sell a generic version of remdesivir, but can do so under provisions of a World Trade Organization agreement.
Related Articles
Trump surrogates hint at how he could reshape U.S. health care policy
Donald Trump’s health care priorities remain fuzzy. But one thing is certain: A second Trump administration would put its own stamp on a host of…
Massive amounts of H5N1 vaccine would be needed if there’s a bird flu pandemic. Can we make enough?
The first signs that H5N1 avian flu was starting to spread from person to person would trigger a race to produce massive amounts of vaccine.
Amid layoffs and a hit to earnings, Bristol’s new CEO shares his vision for the future
Amid layoffs and a hit to earnings, Bristol’s new CEO shares his vision for the future.
The grim reality of relocating to get access to gender-affirming care
No one should be forced to choose between the community they call home and being able to access the care their children need.
Evidence of H5N1 bird flu found in grocery milk
Genetic evidence of the H5N1 bird flu virus was found in grocery store milk in the United States this week, according to the Food and…
Generative AI is supposed to save doctors from burnout. New data show it needs more training
New research from academic hospitals reveals significant limitations of large language models (LLMs) in medical settings.
Chocolate milk will stay on school lunch menus, as USDA reverses course
The USDA will instead enforce a limit on added sugars in chocolate and other flavored milk served in schools starting in the fall of 2025.
After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
A new Science paper from the Baker lab details a novel method for quickly compiling a large library of macrocycle drug candidates.
Vertex offers limited access to a cystic fibrosis drug in South Africa — and may undercut a court case
“This is not a solution for all South African patients” and is “likely to widen the disparity between rich and poor,” advocates complained.
FTC’s noncompete ban would force sweeping changes in health care, if it survives legal battle
The FTC’s noncompete ban could force sweeping changes in the health care industry, but implementation of the rule will almost certainly be held up by…